Application 215700
- Type
- NDA
- Sponsor
- INFORLIFE SA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE | NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE | INJECTABLE;INJECTION | 4MG(16MCG PER ML)0.9% | No | No |
| 002 | NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE | NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE | INJECTABLE;INJECTION | 8MG(32MCG PER ML)0.9% | No | No |
| 003 | NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE | NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE | INJECTABLE;INJECTION | 16MG(64MCG PER ML)0.9% | No | No |
| 004 | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | NOREPINEPHRINE BITARTRATE | SOLUTION;INTRAVENOUS | EQ 32MG BASE/250ML (EQ 128MCG BASE/ML) | Yes | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 44567-640 | NOREPINEPHRINE BITARTRATE | NOREPINEPHRINE BITARTRATE | WG Critical Care, LLC | NDA | Current |
| 44567-640 | NOREPINEPHRINE BITARTRATE | NOREPINEPHRINE BITARTRATE | WG Critical Care, LLC | NDA | Current |
| 44567-640 | NOREPINEPHRINE BITARTRATE | NOREPINEPHRINE BITARTRATE | WG Critical Care, LLC | NDA | Current |
| 44567-641 | NOREPINEPHRINE BITARTRATE | NOREPINEPHRINE BITARTRATE | WG Critical Care, LLC | NDA | Current |
| 44567-641 | NOREPINEPHRINE BITARTRATE | NOREPINEPHRINE BITARTRATE | WG Critical Care, LLC | NDA | Current |
| 44567-641 | NOREPINEPHRINE BITARTRATE | NOREPINEPHRINE BITARTRATE | WG Critical Care, LLC | NDA | Current |
| 44567-642 | NOREPINEPHRINE BITARTRATE | NOREPINEPHRINE BITARTRATE | WG Critical Care, LLC | NDA | Current |
| 44567-642 | NOREPINEPHRINE BITARTRATE | NOREPINEPHRINE BITARTRATE | WG Critical Care, LLC | NDA | Current |
| 44567-642 | NOREPINEPHRINE BITARTRATE | NOREPINEPHRINE BITARTRATE | WG Critical Care, LLC | NDA | Current |